Home
PB Ratio of Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd
NSE: GLENMARK
PB Ratio
Key Highlights
- The latest PB Ratio of Glenmark Pharmaceuticals Ltd is 5.2.
- The PB ratio of the Glenmark Pharmaceuticals Ltd is above 3 which indicates that the stock is overvalued but this is common in high-growing sectors.
- The P/B Ratio of Glenmark Pharmaceuticals Ltd changed from 1 on March 2020 to 3.4 on March 2024 . This represents a CAGR of 27.73% over 5 years.
Historical P/B Ratio of Glenmark Pharmaceuticals Ltd
The price-to-book (P/B) ratio compares a company's market capitalization to its book value by dividing its stock price per share by its book value per share. How to calculate Price-to-Book (P/B) Ratio? The Price-to-Book Ratio is used to determine the relationship between the total value of a company's outstanding shares and the net value of its assets. Before calculating the P/B ratio, investors need to overlook the market capitalization of a company. Market capitalization = market value of a stock X no. of outstanding shares Now, you need to know the net value of an organization's assets. Book Value of Assets = Total Assets - Total Liabilities of a company After knowing the value of the above ratios, here is the formula for the P/B Ratio: P/B Ratio = Market Capitalization/ Book Value of Assets or you can also use this formula P/B ratio = Market Price Per Share/ Book Value of Asset Per Share
Historical P/B Ratio of Glenmark Pharmaceuticals Ltd
Company Fundamentals for Glenmark Pharmaceuticals Ltd
Market Cap
43,458 Cr
EPS
0.0
P/E Ratio (TTM)
0.0
P/B Ratio (TTM)
5.2
Day’s High
1546.65
Day’s Low
1502.5
DTE
0.2
ROE
-23.5
52 Week High
1830.05
52 Week Low
954.5
ROCE
17.3
Market Price of Glenmark Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
28 Mar 2025 | 1540.05 |
27 Mar 2025 | 1520.75 |
26 Mar 2025 | 1464.1 |
25 Mar 2025 | 1480.2 |
24 Mar 2025 | 1493.1 |
21 Mar 2025 | 1511.45 |
20 Mar 2025 | 1478.15 |
19 Mar 2025 | 1486.55 |
18 Mar 2025 | 1457.85 |
17 Mar 2025 | 1430.95 |
SWOT Analysis Of Glenmark Pharmaceuticals Ltd
BlinkX Score for Glenmark Pharmaceuticals Ltd
Asset Value vs Market Value of Glenmark Pharmaceuticals Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/B Ratio
Company | PB | Market Cap |
---|
Glenmark Pharmaceuticals Ltd | 5.15 | 43458 |
Sun Pharmaceutical Industries Ltd | 98.3 | 416393 |
Divis Laboratories Ltd | 513.6 | 153258 |
Cipla Ltd | 360.7 | 116434 |
Torrent Pharmaceuticals Ltd | 222.4 | 109469 |
Company | |
---|---|
Glenmark Pharmaceuticals Ltd | 5.15 |
Sun Pharmaceutical Industries Ltd | 98.3 |
Divis Laboratories Ltd | 513.6 |
Cipla Ltd | 360.7 |
Torrent Pharmaceuticals Ltd | 222.4 |
PB Ratio of Glenmark Pharmaceuticals Ltd Explained
₹43458
Market cap
₹299
Book Value per Share
5.2X
PB Ratio
The price-to-book (P/B) ratio compares a company's market capitalization to its book value by dividing its stock price per share by its book value per share.
How to calculate Price-to-Book (P/B) Ratio?
The Price-to-Book Ratio is used to determine the relationship between the total value of a company's outstanding shares and the net value of its assets. Before calculating the P/B ratio, investors need to overlook the market capitalization of a company.
Market capitalization = market value of a stock X no. of outstanding shares
Now, you need to know the net value of an organization's assets.
Book Value of Assets = Total Assets - Total Liabilities of a company
After knowing the value of the above ratios, here is the formula for the P/B Ratio:
P/B Ratio = Market Capitalization/ Book Value of Assets
or you can also use this formula
P/B ratio = Market Price Per Share/ Book Value of Asset Per Share
Historical Market Cap of Glenmark Pharmaceuticals Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Glenmark Pharmaceuticals Ltd
Market Cap
Historical Revenue, EBITDA and Net Profit of Glenmark Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Glenmark Pharmaceuticals Ltd
Revenue
EBITDA
Net Profit
Dividend Payout Over Time
Glenmark Pharmaceuticals Ltd News Hub
Glenmark Pharmaceuticals Ltd spurts 2.5%, rises for fifth straight session
Glenmark Pharmaceuticals Ltd gained for a fifth straight session today. The stock is quoting at Rs 1
Read more
21 Aug 24
Glenmark Pharmaceuticals Ltd soars 4.33%, rises for third straight session
Glenmark Pharmaceuticals Ltd rose for a third straight session today. The stock is quoting at Rs 163
Read more
19 Aug 24
Glenmark Pharma gains after American subsidiary launches Olopatadine generic
The solution is the generic version of 'Pataday Twice Daily Relief', which is distributed by Alcon L
Read more
19 Aug 24
Glenmark launches Olopatadine Hydrochloride Ophthalmic Solution
Glenmark Therapeutics Inc., USA (Glenmark) has launched Olopatadine Hydrochloride Ophthalmic Solutio
Read more
19 Aug 24